{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:28:30Z","timestamp":1782109710725,"version":"3.54.5"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00347-018-0683-3","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T10:32:52Z","timestamp":1520418772000},"page":"454-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fr\u00fchgeborenenretinopathie","Retinopathy of prematurity"],"prefix":"10.1007","volume":"115","author":[{"given":"T. U.","family":"Krohne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"683_CR1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00347-012-2615-y","volume":"109","author":"TU Krohne","year":"2012","unstructured":"Krohne TU (2012) Retinopathy of prematurity: current aspects of pathogenesis, diagnostics and therapy. Ophthalmologe 109:1173\u20131173. \n                    https:\/\/doi.org\/10.1007\/s00347-012-2615-y","journal-title":"Ophthalmologe"},{"key":"683_CR2","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00347-012-2618-8","volume":"109","author":"TU Krohne","year":"2012","unstructured":"Krohne TU, Aisenbrey S, Holz FG (2012) Current therapeutic options in retinopathy of prematurity. Ophthalmologe 109:1189\u20131197. \n                    https:\/\/doi.org\/10.1007\/s00347-012-2618-8","journal-title":"Ophthalmologe"},{"key":"683_CR3","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s00347-012-2617-9","volume":"109","author":"I Oberacher-Velten","year":"2012","unstructured":"Oberacher-Velten I, Segerer H, Helbig H (2012) Ophthalmological screening for retinopathy of prematurity. Ophthalmologe 109:1182\u20131188. \n                    https:\/\/doi.org\/10.1007\/s00347-012-2617-9","journal-title":"Ophthalmologe"},{"key":"683_CR4","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1007\/s00347-012-2616-x","volume":"109","author":"A Stahl","year":"2012","unstructured":"Stahl A, Lagr\u00e8ze WA, Agostini HT (2012) Pathogenesis of retinopathy of prematurity. Ophthalmologe 109:1174\u20131181. \n                    https:\/\/doi.org\/10.1007\/s00347-012-2616-x","journal-title":"Ophthalmologe"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-018-0683-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0683-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0683-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T20:09:28Z","timestamp":1551902968000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-018-0683-3"}},"subtitle":["Aktuelle Entwicklungen in Therapie und Epidemiologie","Current developments in therapy and epidemiology"],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["683"],"URL":"https:\/\/doi.org\/10.1007\/s00347-018-0683-3","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]},"assertion":[{"value":"7 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.U.\u00a0Krohne: Alimera Sciences, Bayer, Heidelberg Engineering, Novartis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}